The head of an association of state cannabis regulators said Friday that the Drug Enforcement Administration has left regulators without answers as a Nov. 29 compliance deadline approaches that could split state medical marijuana markets in two.
Gillian Schauer, executive director of the Cannabis Regulators Association, warned that medical marijuana patients in some states could find their dispensaries short of product, or closed, when the deadline takes effect on the Sunday after Thanksgiving.
“If you’re a patient in a remote area, you’ve been using a certain medical cannabis product for a long time, your dispensary that’s in your area may no longer carry that product or may have to go out of business because they don’t have enough supplies,” she said.
People were interested in these podcasts
The deadline stems from an Oct. 30 DEA email to businesses that applied for federal registration within a 60-day window.
Speaking at a webinar hosted Friday by the Coalition for Cannabis Scheduling Reform, an industry campaign led by the American Trade Association for Cannabis & Hemp, Shane Pennington, an attorney with Blank Rome who’s on the coalition’s legal team, said the April order promised expedited processing and let applicants keep operating under state law while the DEA reviewed their applications.
The email says that by Nov. 29, “timely applicants” may deal only with other timely applicants and DEA registrants, Mr. Pennington said.
Jason Adelstone of law firm Harris Sliwoski, who is also on the coalition’s legal team, said that would cut off businesses that missed the window.
Mr. Pennington is challenging the guidance in the U.S. Court of Appeals for the D.C. Circuit.
He argued the DEA changed the rules by email, skipping the public comment period the law requires.
“It’s just an email that’s dropping new obligations from heaven or hell, depending on your point of view,” he said.
The DEA has said the guidance lacks the force and effect of law, moderator Michael Bronstein, president of the trade association, said, though noncompliance can lead to a denied application.
The four panelists, including two attorneys on the coalition’s legal team, were critical of the agency.
Ms. Schauer, who said she does not speak for all regulators, said headquarters has not met with regulators or answered basic questions, such as how states with both medical and adult-use licenses fit in.
Some states report that all their testing labs are seeking DEA registration, she said, which could leave none to test state-regulated product.

Please read our comment policy before commenting.